Status:
ACTIVE_NOT_RECRUITING
Effect of Longitudinal Sleep Monitoring on Diagnosis and Treatment Decision in Patients with Suspected Obstructive Sleep Apnea
Lead Sponsor:
Malcolm Kohler
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive sleep apnea (OSA) is a highly prevalent sleep-disordered breathing disease, caused by recurrent episodes of partial or complete collapse of the upper airway during sleep, resulting in inte...
Eligibility Criteria
Inclusion
- Informed consent
- Suspected obstructive sleep apnea
- ≥18 years old
Exclusion
- Suspected or diagnosed sleeping-disordered breathing other than OSA
- Moribund or severe disease prohibiting protocol adherence especially COPD GOLD III-IV and heart failure NYHA III-IV
- Patients receiving oxygen therapy or home ventilation
- Continuous positive airway pressure treatment for OSA at baseline
- Physical or intellectual impairment precluding informed consent or protocol adherence
- Pregnant patients
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT03819361
Start Date
February 1 2019
End Date
April 30 2025
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091